Daniel M. Junius - Dec 5, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Stock symbol
IDXX
Transactions as of
Dec 5, 2022
Transactions value $
-$806,063
Form type
4
Date filed
12/7/2022, 03:30 PM
Previous filing
Nov 18, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $488K +3.05K +102.63% $160.28 6.01K Dec 5, 2022 Direct
transaction IDXX Common Stock Sale -$1.29M -3.05K -50.65% $424.91 2.97K Dec 5, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -3.05K -100% 0 Dec 5, 2022 Common Stock 3.05K $160.28 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy 3,046 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of shareholders, whichever event was earlier.
F2 Not applicable.